{"id":28663,"date":"2025-03-04T16:10:51","date_gmt":"2025-03-04T08:10:51","guid":{"rendered":"https:\/\/flcube.com\/?p=28663"},"modified":"2025-03-04T16:10:53","modified_gmt":"2025-03-04T08:10:53","slug":"waters-and-kehuas-lc-ms-systems-gain-nmpa-approval-for-ivd-use","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=28663","title":{"rendered":"Waters and Kehua’s LC-MS Systems Gain NMPA Approval for IVD Use"},"content":{"rendered":"\n

Two home-grown liquid chromatography with tandem mass spectrometry (LC-MS) systems, the ACQUITY UPLC I-Class PLUS \/ Xevo TQ-Loong System and the ACQUITY UPLC I-Class PLUS \/ Xevo TQ-S cronos System, have obtained marketing approvals from the National Medical Products Administration (NMPA). These products, developed jointly by US firm Waters Corporation (NYSE: WAT<\/a>) and China’s Shanghai Kehua Bioengineering Co., Ltd (SHE: 002022<\/a>), are used in clinical settings for qualitative or quantitative detection of endogenous (vitamins, amino acids, hormones, organic acids) or exogenous (therapeutic drugs) analytes in human biological samples, including whole blood, plasma, serum, and urine.<\/p>\n\n\n\n

Product Highlights<\/strong>
The ACQUITY UPLC I-Class PLUS \/ Xevo TQ-Loong System is designed to meet the demanding requirements of UPLC-MS \/ MS quantitative analysis. Its excellent performance allows for the accurate quantification of trace analytes in complex clinical matrices, providing robust data support for clinical research. Meanwhile, the ACQUITY UPLC I-Class PLUS \/ Evo TQ-S cronos System offers stable performance and excellent cost-effectiveness, making it suitable for routine quantitative analysis in clinical laboratories.-Fineline Info & Tech<\/a><\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Two home-grown liquid chromatography with tandem mass spectrometry (LC-MS) systems, the ACQUITY UPLC I-Class PLUS…<\/p>\n","protected":false},"author":1,"featured_media":28665,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,22],"tags":[611,3808,15,1308,3807],"class_list":["post-28663","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-medical-device","tag-kehua-bioengineering","tag-nyse-wat","tag-product-approvals","tag-she-002022","tag-waters"],"yoast_head":"\nWaters and Kehua's LC-MS Systems Gain NMPA Approval for IVD Use - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Two home-grown liquid chromatography with tandem mass spectrometry (LC-MS) systems, the ACQUITY UPLC I-Class PLUS \/ Xevo TQ-Loong System and the ACQUITY UPLC I-Class PLUS \/ Xevo TQ-S cronos System, have obtained marketing approvals from the National Medical Products Administration (NMPA). These products, developed jointly by US firm Waters Corporation (NYSE: WAT) and China's Shanghai Kehua Bioengineering Co., Ltd (SHE: 002022), are used in clinical settings for qualitative or quantitative detection of endogenous (vitamins, amino acids, hormones, organic acids) or exogenous (therapeutic drugs) analytes in human biological samples, including whole blood, plasma, serum, and urine.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=28663\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Waters and Kehua's LC-MS Systems Gain NMPA Approval for IVD Use\" \/>\n<meta property=\"og:description\" content=\"Two home-grown liquid chromatography with tandem mass spectrometry (LC-MS) systems, the ACQUITY UPLC I-Class PLUS \/ Xevo TQ-Loong System and the ACQUITY UPLC I-Class PLUS \/ Xevo TQ-S cronos System, have obtained marketing approvals from the National Medical Products Administration (NMPA). These products, developed jointly by US firm Waters Corporation (NYSE: WAT) and China's Shanghai Kehua Bioengineering Co., Ltd (SHE: 002022), are used in clinical settings for qualitative or quantitative detection of endogenous (vitamins, amino acids, hormones, organic acids) or exogenous (therapeutic drugs) analytes in human biological samples, including whole blood, plasma, serum, and urine.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=28663\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-04T08:10:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-04T08:10:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0411-png.avif\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"604\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28663#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28663\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Waters and Kehua’s LC-MS Systems Gain NMPA Approval for IVD Use\",\"datePublished\":\"2025-03-04T08:10:51+00:00\",\"dateModified\":\"2025-03-04T08:10:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28663\"},\"wordCount\":179,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28663#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/0411-png.avif\",\"keywords\":[\"Kehua Bioengineering\",\"NYSE: WAT\",\"Product approvals\",\"SHE: 002022\",\"Waters\"],\"articleSection\":[\"Company\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=28663#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28663\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=28663\",\"name\":\"Waters and Kehua's LC-MS Systems Gain NMPA Approval for IVD Use - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28663#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28663#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/0411-png.avif\",\"datePublished\":\"2025-03-04T08:10:51+00:00\",\"dateModified\":\"2025-03-04T08:10:53+00:00\",\"description\":\"Two home-grown liquid chromatography with tandem mass spectrometry (LC-MS) systems, the ACQUITY UPLC I-Class PLUS \\\/ Xevo TQ-Loong System and the ACQUITY UPLC I-Class PLUS \\\/ Xevo TQ-S cronos System, have obtained marketing approvals from the National Medical Products Administration (NMPA). These products, developed jointly by US firm Waters Corporation (NYSE: WAT) and China's Shanghai Kehua Bioengineering Co., Ltd (SHE: 002022), are used in clinical settings for qualitative or quantitative detection of endogenous (vitamins, amino acids, hormones, organic acids) or exogenous (therapeutic drugs) analytes in human biological samples, including whole blood, plasma, serum, and urine.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28663#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=28663\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28663#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/0411-png.avif\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/0411-png.avif\",\"width\":1080,\"height\":604,\"caption\":\"Waters and Kehua's LC-MS Systems Gain NMPA Approval for IVD Use\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28663#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Waters and Kehua’s LC-MS Systems Gain NMPA Approval for IVD Use\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Waters and Kehua's LC-MS Systems Gain NMPA Approval for IVD Use - Insight, China's Pharmaceutical Industry","description":"Two home-grown liquid chromatography with tandem mass spectrometry (LC-MS) systems, the ACQUITY UPLC I-Class PLUS \/ Xevo TQ-Loong System and the ACQUITY UPLC I-Class PLUS \/ Xevo TQ-S cronos System, have obtained marketing approvals from the National Medical Products Administration (NMPA). These products, developed jointly by US firm Waters Corporation (NYSE: WAT) and China's Shanghai Kehua Bioengineering Co., Ltd (SHE: 002022), are used in clinical settings for qualitative or quantitative detection of endogenous (vitamins, amino acids, hormones, organic acids) or exogenous (therapeutic drugs) analytes in human biological samples, including whole blood, plasma, serum, and urine.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=28663","og_locale":"en_US","og_type":"article","og_title":"Waters and Kehua's LC-MS Systems Gain NMPA Approval for IVD Use","og_description":"Two home-grown liquid chromatography with tandem mass spectrometry (LC-MS) systems, the ACQUITY UPLC I-Class PLUS \/ Xevo TQ-Loong System and the ACQUITY UPLC I-Class PLUS \/ Xevo TQ-S cronos System, have obtained marketing approvals from the National Medical Products Administration (NMPA). These products, developed jointly by US firm Waters Corporation (NYSE: WAT) and China's Shanghai Kehua Bioengineering Co., Ltd (SHE: 002022), are used in clinical settings for qualitative or quantitative detection of endogenous (vitamins, amino acids, hormones, organic acids) or exogenous (therapeutic drugs) analytes in human biological samples, including whole blood, plasma, serum, and urine.","og_url":"https:\/\/flcube.com\/?p=28663","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-03-04T08:10:51+00:00","article_modified_time":"2025-03-04T08:10:53+00:00","og_image":[{"width":1080,"height":604,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0411-png.avif","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=28663#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=28663"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Waters and Kehua’s LC-MS Systems Gain NMPA Approval for IVD Use","datePublished":"2025-03-04T08:10:51+00:00","dateModified":"2025-03-04T08:10:53+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=28663"},"wordCount":179,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=28663#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0411-png.avif","keywords":["Kehua Bioengineering","NYSE: WAT","Product approvals","SHE: 002022","Waters"],"articleSection":["Company","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=28663#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=28663","url":"https:\/\/flcube.com\/?p=28663","name":"Waters and Kehua's LC-MS Systems Gain NMPA Approval for IVD Use - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=28663#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=28663#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0411-png.avif","datePublished":"2025-03-04T08:10:51+00:00","dateModified":"2025-03-04T08:10:53+00:00","description":"Two home-grown liquid chromatography with tandem mass spectrometry (LC-MS) systems, the ACQUITY UPLC I-Class PLUS \/ Xevo TQ-Loong System and the ACQUITY UPLC I-Class PLUS \/ Xevo TQ-S cronos System, have obtained marketing approvals from the National Medical Products Administration (NMPA). These products, developed jointly by US firm Waters Corporation (NYSE: WAT) and China's Shanghai Kehua Bioengineering Co., Ltd (SHE: 002022), are used in clinical settings for qualitative or quantitative detection of endogenous (vitamins, amino acids, hormones, organic acids) or exogenous (therapeutic drugs) analytes in human biological samples, including whole blood, plasma, serum, and urine.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=28663#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=28663"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=28663#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0411-png.avif","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0411-png.avif","width":1080,"height":604,"caption":"Waters and Kehua's LC-MS Systems Gain NMPA Approval for IVD Use"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=28663#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Waters and Kehua’s LC-MS Systems Gain NMPA Approval for IVD Use"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0411-png.avif","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/28663","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=28663"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/28663\/revisions"}],"predecessor-version":[{"id":28666,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/28663\/revisions\/28666"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/28665"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=28663"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=28663"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=28663"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}